Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
about
Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
P2860
Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@ast
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@en
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@nl
type
label
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@ast
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@en
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@nl
prefLabel
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@ast
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@en
Side effect profile of 5-HT tr ...... PA-induced dyskinesia in rats.
@nl
P2093
P2860
P356
P1476
Side effect profile of 5-HT tr ...... OPA-induced dyskinesia in rats
@en
P2093
P2860
P304
P356
10.1111/BPH.12894
P407
P577
2014-11-24T00:00:00Z